METHOTREXATE BIODIM 5 mg/2 ml, solution for injection bottle, 2 ml
Brand page: Novatrex, Imeth (methotrexate) — all forms and strengths in France
Active ingredients: Methotrexate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 2 mlintraartérielle;intramusculaire;intrathécale;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METHOTREXATE BIODIM 5 mg/2 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intramusculaire;intrathécale;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 2 ml
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67961853CIP73150125CIP133400931501251Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOTREXATEsolution | 5 mg · 2 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.